Management of advanced carcinoma of the vulva

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2026

Trehalose Exerts Selective Cytotoxicity Against Tongue Squamous Cell Carcinoma Cells While Exhibiting Limited Cytotoxicity Toward Normal Oral Squamous Cells.

OncoTargets and therapy·2026

Pathological Complete Response following Pembrolizumab Combined with Gemcitabine and Cisplatin Therapy for Initially Unresectable Intrahepatic Cholangiocarcinoma: A Case Report.

Case reports in oncology·2026

Anti-angiogenic therapy in thymic carcinoma: a narrative review of current evidence and emerging combinations.

Mediastinum (Hong Kong, China)·2026

Narrative review: locally advanced thymoma-do we really need induction therapy before extended resection?

Mediastinum (Hong Kong, China)·2026

Invasive thymoma with rapid response to cisplatin, doxorubicin and cyclophosphamide (PAC) chemotherapy, after an early postoperative recurrence-a case report.

Mediastinum (Hong Kong, China)·2026

Related Experiment Videos

Management of advanced carcinoma of the vulva

Related Concept Videos

Use of patient ethnography to support quality improvement in benign prostatic hyperplasia.

Measuring the cost of care in benign prostatic hyperplasia using time-driven activity-based costing (TDABC).

Detection of chromosomal aberrations by fluorescence in situ hybridization in cervicovaginal biopsies from women exposed to diethylstilbestrol in utero.

High-risk endometrial cancer in young indigent women.

Uterine evacuation with misoprostol during radiotherapy for cervical cancer in pregnancy.

Adenovirus-mediated thymidine kinase gene therapy for recurrent ovarian cancer: expression of coxsackie-adenovirus receptor and integrins alphavbeta3 and alphavbeta5.

Long-term efficacy and safety of avutometinib + defactinib in recurrent low-grade serous ovarian cancer: Results of a 2-year follow-up of ENGOT-OV60/GOG-3052/RAMP 201.

Prognostic implications of HPV and TP53 status in early-stage vulvar squamous cell carcinoma.

Planning and feasibility of phase III surgical trials in gynecologic oncology.

Minimally invasive surgery without a uterine manipulator versus open radical hysterectomy for early-stage cervical cancer: A retrospective propensity-score-matched single-center cohort study.

Mutated p53 results in altered type I interferon pathway expression and signaling in endometrial cancer.

Molecular groups predict response to fertility-sparing treatment of endometrial carcinoma: a systematic review and metanalysis.

Confounding by indication in the evaluation of neoadjuvant chemotherapy: a sequential Cox analysis of an eight-year single-centre breast cancer cohort.

Trehalose Exerts Selective Cytotoxicity Against Tongue Squamous Cell Carcinoma Cells While Exhibiting Limited Cytotoxicity Toward Normal Oral Squamous Cells.

Pathological Complete Response following Pembrolizumab Combined with Gemcitabine and Cisplatin Therapy for Initially Unresectable Intrahepatic Cholangiocarcinoma: A Case Report.

Anti-angiogenic therapy in thymic carcinoma: a narrative review of current evidence and emerging combinations.

Narrative review: locally advanced thymoma-do we really need induction therapy before extended resection?

Invasive thymoma with rapid response to cisplatin, doxorubicin and cyclophosphamide (PAC) chemotherapy, after an early postoperative recurrence-a case report.

Related Experiment Videos

Management of advanced carcinoma of the vulva

Related Concept Videos

Related Articles